Biosimilars

Bio-Thera Reports the US FDA’s Approval of Avzivi (Biosimilar, Avastin)

Bio-Thera Reports the US FDA’s Approval of Avzivi (Biosimilar, Avastin)

Shots: The FDA granted approval to Avzivi (BAT1706) based on a thorough analysis o...

Samsung Bioepis Successfully Resolves Patent Disputes with Johnson & Johnson

Samsung Bioepis Successfully Resolves Patent Disputes with Johnson & Johnson

Shots: Samsung Bioepis has successfully resolved all patent litigation with Johnso...

Alvotech Reports Results from the Study of AVT05, Biosimilar Candidate to Simponi and Simponi Aria (golimumab)

Alvotech Reports Results from the Study of AVT05, Biosimilar Candidate to Simponi and Simponi Aria (golimumab)

Shots: Alvotech has announced top-line results from a PK trial investigating AVT05...

Formycon and its License Partner Klinge Biopharma Reports the BLA Submission of FYB203 (Biosimilar, Eylea) to the EMA

Formycon and its License Partner Klinge Biopharma Reports the BLA Submission of FYB203 (Biosimilar, Eylea) to the EMA

Shots: Formycon and its license partner Klinge Biopharma submitted the BLA for FYB...

Sandoz Introduces High-Concentration Formulation of Hyrimoz in Europe

Sandoz Introduces High-Concentration Formulation of Hyrimoz in Europe

Shots: The company has launched Hyrimoz (Biosimilar, adalimumab) citrate-free high...

Image